phenoxazinone has been researched along with vincristine in 1 studies
| Studies (phenoxazinone) | Trials (phenoxazinone) | Recent Studies (post-2010) (phenoxazinone) | Studies (vincristine) | Trials (vincristine) | Recent Studies (post-2010) (vincristine) |
|---|---|---|---|---|---|
| 55 | 0 | 17 | 246 | 0 | 117 |
| Protein | Taxonomy | phenoxazinone (IC50) | vincristine (IC50) |
|---|---|---|---|
| Tubulin beta-4A chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta chain | Homo sapiens (human) | 0.5 | |
| Tubulin alpha-3C chain | Homo sapiens (human) | 0.5 | |
| Tubulin alpha-1B chain | Homo sapiens (human) | 0.5 | |
| Tubulin alpha-4A chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-4B chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-2A chain | Homo sapiens (human) | 0.5 | |
| Beta-tubulin | Leishmania donovani | 1 | |
| Tubulin beta-8 chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-2B chain | Bos taurus (cattle) | 1.8 | |
| Tubulin alpha-3E chain | Homo sapiens (human) | 0.5 | |
| Tubulin alpha-1A chain | Homo sapiens (human) | 0.5 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 1.8 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 1.8 | |
| Tubulin alpha-1C chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-6 chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-2B chain | Homo sapiens (human) | 0.5 | |
| Tubulin beta-1 chain | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barone, V; Bolognese, A; Correale, G; La Colla, P; Lavecchia, A; Loddo, R; Manfra, M; Mazzoni, O; Murgioni, C; Novellino, E; Pani, A; Serra, I; Setzu, G; Tramontano, E | 1 |
1 other study(ies) available for phenoxazinone and vincristine
| Article | Year |
|---|---|
Antitumor agents. 1. Synthesis, biological evaluation, and molecular modeling of 5H-pyrido[3,2-a]phenoxazin-5-one, a compound with potent antiproliferative activity.
Topics: Antineoplastic Agents; Cell Division; DNA; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Intercalating Agents; Magnetic Resonance Spectroscopy; Models, Molecular; Oxazines; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured | 2002 |